Company intelligence / Profile preview

Nature's Fynd

Chicago, Illinois, United Statesnaturesfynd.com ↗

Ownership: Private
Employees: ~140
Development stage: Commercial

Overview

Nature’s Fynd has launched commercial products using its proprietary Fy Protein™, derived from the extremophile fungus Fusarium strain flavolapis. The products include meatless breakfast patties and dairy-free cream cheese. The process uses non-GMO fermentation and offers high nutritional value with minimal environmental impact. No clinical results as it does not develop therapeutics.

Modalities: Microbial proteinFermentation-derived protein
Industry: Food & Nutrition

Partnerships

Montana State University

Beyond the preview

Go deeper on Nature's Fynd.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nature's Fynd.

Explore the full profile